Restricted accessResearch articleFirst published online 2007-7
Linezolid-Induced Reversible Posterior Leukoencephalopathy Syndrome;Fatal Pulmonary Toxicity after One Dose of Cyclophosphamide;Psychosis following Initiation of Zonisamide;Syndrome of Inappropriate Antidiuresis;Review of Rashes Associated with Antiepileptic Drugs;Review of Drug-Induced Sweet Syndrome
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the Food and Drug Administration's (FDA) medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
ShusterJ.ISMP adverse drug reactions. Hosp Pharm.2007; 42: 501–508.
2.
ShusterJ.ISMP adverse drug reactions. Hosp Pharm.2006; 41: 1026–1027.
